Stocks to watch: Bharti Airtel, Bharti Infratel, Wipro, Apollo Hospital, Tata Chemicals

Capital Market 

Bharti Airtel: The telecom major informed that its wholly-owned subsidiary, Nettle Infrastructure Investments, acquired an additional equity stake of about 4.94% in Bharti lnfratel on Wednesday, 2 December 2020. As on 20 November 2020, Nettle Infrastructure Investments held 13.68% in Bharti Infratel.

Bharti Infratel: The company informed that due to unavoidable reasons, Manish Dawar would not be able to join the company as the chief financial officer.

Apollo Hospital Enterprises: The company's board approved the proposal to raise upto Rs 1,500 crore in one or more tranches through further issue of securities on a preferential allotment basis and/or through Qualified Institutional Placement (QIP).

Wipro: The IT major announced that it has won a multi-year contract from Verifone, a global leader in payments and commerce solutions, to drive agility across its cloud services offerings.

Tata Chemicals: On Wednesday (2 December), promoter Tata Sons bought 18,07,245 shares (0.7% equity) of Tata Chemicals at Rs 420.92 per share via bulk deal on the NSE. It held 29.39% stake in the company at the end of September.

Snowman Logistics: On Wednesday (2 December), Adani Logistics sold 9,59,356 equity shares of the company at Rs 55.64 per share via bulk deal on the NSE. Adani Logistics held 26% stake in the company at the end of September.

Indoco Remedies: On Wednesday (2 December), Dovetail India Fund Class 6 Shares bought 5 lakh shares (0.54% equity) of the company at Rs 265.31 per share via bulk deal on the NSE. OHM Juniper Longterm Fund was the seller of these shares at same price.

Fermenta Biotech: The company's wholly owned subsidiary, Fermenta Biotech USA, has acquired a membership interest in AGD Nutrition for an aggregate consideration of $1,260,500.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Thu, December 03 2020. 08:57 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU